We are pleased to announce that the Prometheus MedTech.AI team has recently completed a productive visit to New York City, marking an important step in our strategic entry into the U.S. healthcare ecosystem. During our time on site, we initiated collaboration with two respected clinical institutions, laying the groundwork for long-term research and development initiatives.
As part of this visit, our team engaged with clinical staff to present and demonstrate our AI-powered ultrasound solutions in real-world environments. This provided valuable insights into the operational workflows of large urban clinics and opened new opportunities for gathering diverse clinical data—an essential component in preparing for regulatory requirements, including future FDA submissions.
We extend our sincere thanks to Raveco Medical OB/GYN (Dr. Steven Ravins, MD) and HJC MEDICINE PLLC (Dr. Hajoon Chun, MD) for their openness, professionalism, and collaborative spirit, which have been invaluable as we work together to advance fetal and neonatal cardiac diagnostics through AI-enhanced ultrasound technologies. We look forward to the months ahead, which will bring joint research initiatives, scientific publications, and continued co-development.
This visit marks the beginning of a broader U.S. expansion effort focused on collaboration, scientific excellence, and delivering real-world impact through responsible medical AI.
How can technology support health? At Prometheus MedTech.AI, we believe in empowering clinicians with smarter tools — technology that enhances…
Prometheus MedTech.AI received the Main Award at the Deeptech Accelerator DemoDay held during the Podkarpackie Science and Innovation Festival in…
At ECAI 2025 in Bologna — Europe’s leading conference dedicated to artificial intelligence — we presented PrAViC, a probabilistic framework…
We’re proud to share that Prometheus MedTech.AI has received the “Visionary of the Polish Economy” Award named after Marek Goliszewski, presented…
We’re proud to be ranked among the Top 3 AI startups in healthcare globally and the Top 15 medical startups overall…
Prometheus MedTech.AI has been named one of the Top 40 most promising startups in the prestigious K-Startup Grand Challenge 2025 (KSGC) —…
Prometheus MedTech.AI has taken a major step toward its U.S. market entry and future FDA certification by participating in NeoHeart 2025…
We’re proud to announce that our innovative solution, Ultra Echo Scan (UES), has been selected among the Top 80 startups worldwide for the…
We are pleased to announce that the Prometheus MedTech.AI team has recently completed a productive visit to New York City, marking…
From the Top 10 Health Startups in Europe to the stage in Madrid — our team joined one of the world’s most prestigious innovation summits to connect, pitch, and share our mission.
We are proud to announce that UES Sp. z o.o. has received European Union funding to support the international expansion of our…
We are thrilled to announce that Prometheus MedTech.AI has been selected as one of the Top 10 startups in the Health category at South Summit…